GE, Clarient Move MultiOmyx Platform into Clinic with Launch of Hodgkin Diagnostic | GenomeWeb

With the launch this month of its Hodgkin Lymphoma Profile diagnostic, GE Healthcare has moved its MultiOmyx protein detection system into the clinical arena.

Offered through the company's Clarient Diagnostic Services, the HL Profile test assesses the levels of nine proteins linked to Hodgkin, and is intended as an aid to diagnose the disease where conventional methods are either impractical or insufficient.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.